News

Intercell submits marketing authorization application (MAA) to EMEA for licensure of Japanese Encephalitis ...

Intercell submits marketing authorization application (MAA) to EMEA for licensure of Japanese Encephalitis Vaccine

Martin Nowak: Five Rules for Cooperation

Time: 5. 12. 2007, 6:15 p.m.
Place: Autidorium of the Austrian Academy of Sciences

Martin Nowak, Harvard University,...

Statens Serum Institut (SSI), Intercell (ICLL), and Aeras Global Tuberculosis Vaccine Foundation (Aeras) an...

Statens Serum Institut (SSI), Intercell (ICLL), and Aeras Global Tuberculosis Vaccine Foundation (Aeras) announce the...

FWF: Visiting scientists programme Translational Brainpower - Deadline for applications: 27. 3. 2008

The programme goals and Guidelines for applicants for the Translational Research Programme (TRP) are valid. For...

FWF: New Call for Translational Research Projects, Deadline: 27. 3. 2008

The Austrian Science Fund FWF announces a new Call for Translational Research Projects.

Target group:
- Scientists of any...

Fibrex Medical completes enrolment of Phase II trial of treatment for reperfusion injury in myocardial infa...

Fibrex Medical completes enrolment of Phase II trial of treatment for reperfusion injury in myocardial infarction

Intercell's clinical data on Japanese Encephalitis vaccine published in The Lancet

» Intercell´s (ICLL) Phase III clinical trial results on its investigational Japanese Encephalitis vaccine have been...

Antibody engineering company f-star raises EUR 3 million in a second closing of its series A financing roun...

Antibody engineering company f-star raises EUR 3 million in a second closing of its series A financing round from Novo...

Spotlight on life sciences funding in Vienna

On November 26, 2007 aws, FFG, FWF, WWTF and ZIT will inform about news regarding funding of life sciences at the Vienna...

Intercell-Novartis alliance - next EUR 80 million payment received

» EUR 80 m upfront license and opt-in fee paid by Novartis

» Development of key products within the Novartis alliance...

Affiris granted European patent for Alzheimer's vaccine

Affiris GmbH has been granted a Europe-wide patent for key elements of its Alzheimer's vaccine. As a result, the company...

WWTF: Four new Science Chairs for Vienna

WWTF announced to fund four new Science Chairs in life sciences and cognitive sciences in 2008 with in total EUR 6...

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on then-current expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? Just send your contributions to news(at)lisavienna.at.